Efficacy and safety of nebulized drugs in the treatment of non-severe <i>mycoplasma</i> pneumoniae pneumonia in children - a network meta-analysis.

ABSTRACT:

Objective

To systematically evaluate the efficacy and safety of commonly used nebulized drugs as adjuvant treatment for non-severe mycoplasma pneumoniae pneumonia (MPP) in children, providing an evidence-based reference for clinical medication.

Methods

A computerized search of major Chinese and English literature databases was conducted to collect randomized controlled trials (RCTs) that utilized nebulized drugs in conjunction with azithromycin (AZM) or AZM alone in children with MPP. Following literature screening, the quality of the included studies was evaluated using the risk of bias assessment tool as recommended by the Cochrane Handbook. Outcome data for each measurement were extracted, and a network meta-analysis was conducted using Stata 17.0.

Results

A

SUBMITTER: Zeng L 

PROVIDER: S-EPMC12436391 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature